- Hands can often feel numb or lose feeling.
- Numbness can come from many different causes.
- A wrong diagnosis can delay needed treatment.
- Wrong treatment can let symptoms continue.
- Numbness can make holding things and buttoning hard.
- You may drop objects or lose grip strength.
- See a doctor if numbness lasts many weeks.
- Night numbness that wakes you needs medical help.
- Do not ignore sudden weakness or clumsy hands.
- Talk to a health professional for advice.
Difficult words
- numbness — loss of feeling in a part of the body
- diagnosis — a doctor's identification of an illness
- treatment — medical care to help a health problem
- symptom — a sign that shows an illnesssymptoms
- grip — the strength to hold things
- professional — a trained person who gives medical advicehealth professional
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever felt numbness in your hands?
- Would you see a doctor if numbness lasted many weeks?
- Do you talk to a health professional when you need advice?
Related articles
Mental health conditions raise risk of injury
A large study in Nature Mental Health found people with mental health conditions have higher risks of self-harm, assault and unintentional injuries. The research used population records and had US federal funding and calls for better prevention.
Some chemotherapy drugs trigger immune attack by mimicking viruses
New research finds that some chemotherapy agents can make cancer cells behave like virus‑infected cells. This viral mimicry activates the innate immune system and could let doctors use lower drug doses with better results.
Experts call for integrated One Health surveillance linking communities
Experts urge governments to build integrated surveillance systems that link community-level data across human, animal, plant and environmental sectors. A virtual roundtable highlighted research priorities and named integrated surveillance the most urgent need.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.